micardis and avapro
SEATTLE – The latest data from a phase 3 clinical trial shows that gene therapy can counter visual degeneration associated with Leber hereditary optic neuropathy (LHON). The therapy, delivered by intravitreal injection, how long does glyburide take to work uses an adeno-associated virus vector to deliver a corrected copy of the mutated ND4 mitochondrial gene. LHON is a rare, maternally […]
Continue reading »